Is IGF-LR3 FDA approved?
No. This profile records IGF-LR3 as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE MUSCLE MAXIMIZER
Long R3 Insulin-like Growth Factor-1; LR3 IGF-1
IGF-LR3 is a modified version of IGF-1 with a much longer half-life. The modifications make it more potent and longer-lasting than natural IGF-1. It activates muscle satellite cells, promotes protein synthesis, and has powerful anabolic effects, which makes it popular among bodybuilders and those seeking muscle growth.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records IGF-LR3 as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 20-50 mcg daily.
Schedule: daily. Cycle: 4-6 weeks on, 4 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Strongly activates IGF-1 receptors for growth signaling
Stimulates protein synthesis and satellite cell activation
Modified structure resists binding proteins, lasting much longer
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.